Metraipolis › archive › dc_98ed45cc6dfb

The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders — Europe PMC PMID:40588738

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40588738
DOI
10.1186/s12954-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-08T13:22:52.754Z
SHA-256 of the archived text
8f18f8a982c24b33a281548141b119234b480d5696b7548ef1f98f0475869b47
Stable URL of this page
https://metraipolis.com/documento/dc_98ed45cc6dfb

How to cite

The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders — Europe PMC PMID:40588738 — Europe PMC (en), https://europepmc.org/article/MED/40588738 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98ed45cc6dfb (Metraipolis archive dc_98ed45cc6dfb, sha256 8f18f8a982c24b33a281548141b119234b480d5696b7548ef1f98f0475869b47)
BibTeX
@misc{dc98ed45cc6dfb,
  title = {The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders — Europe PMC PMID:40588738},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40588738},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98ed45cc6dfb; sha256 8f18f8a982c24b33a281548141b119234b480d5696b7548ef1f98f0475869b47},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40588738. Agents can read the archived copy with the MCP tool read_document.